Abstract

This paper compares the results of the studies carried out with three new candidate certified reference materials (CRM) of captopril, metronidazole, and sodium diclofenac, which are the first CRMs of these active pharmaceutical ingredients (APIs) reported in the literature. The studies were carried out according to the ISO Guides 34: 2009 and 35: 2006 and included the determination of organic, inorganic, and volatile impurities mass fractions, evaluation of homogeneity and stability under transport and storage conditions, calculation of API mass fractions by mass balance, cross-checking of obtained results, and estimation of measurement uncertainties. The certified property values and corresponding expanded uncertainties, obtained from the combined standard uncertainties multiplied by the coverage factor (k = 2), for a confidence level of 95 %, were (995.65 ± 0.93) mg/g for captopril, (998.87 ± 0.15) mg/g for metronidazole, and (999.76 ± 0.10) mg/g for sodium diclofenac. These new CRMs are intended to be used in assay and tests methods, including equipment calibration, method validation, as well as assignment of traceable property values and corresponding uncertainties to non-certified reference materials, with the objective to ensure metrological traceability of measurement results to the International System of Units, as well as results accuracy and comparability.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.